ExpreS2ion Biotech Holding AB (publ) reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was SEK 2.03 million compared to SEK 1.7 million a year ago. Revenue was SEK 2.08 million compared to SEK 1.93 million a year ago. Net loss was SEK 13.84 million compared to SEK 11.16 million a year ago. Basic loss per share from continuing operations was SEK 0.44 compared to SEK 0.4 a year ago.